eSupervisor Detail

Get to know about the eSupervisor in depth

Sunayana Dagar Profile Picture

Program Leader

Sunayana Dagar

Scientific Writing

Karnataka, India
12 Years
Joined Jun 2026
Avesthagenome Project International Private Limited
Neuroscience
0 Consultations

About me

Ph.D. neuroscientist with 10+ years of research experience across Yale, UF Scripps, and Florida Atlantic University, specializing in neurodegeneration and Huntington's disease. Author of 12 peer-reviewed publications, including 2026 first-author papers in Science Advances and PNAS. A dedicated mentor experienced in guiding students from high school through graduate level in experimental design, data analysis, and scientific writing — translating complex biology into accessible learning.

Interests: My research centers on the molecular and cellular mechanisms of neurodegeneration, with a particular focus on Huntington's disease. I investigate how toxic disease proteins spread between neurons and how cellular stress pathways drive brain degeneration — work aimed at uncovering novel therapeutic targets. My recent contributions include characterizing the Rhes-Slc4a7 signaling complex that governs the cell-to-cell spread of mutant Huntingtin through tunneling nanotubes, and identifying the cGAS-STING neuroinflammatory pathway as a driver of Huntington's disease pathology. Earlier work explored how the cell's structural machinery — the cytoskeleton — shapes intercellular communication and cell migration, relevant to both cancer and neurodegenerative biology. Methodologically, I work across cell and molecular biology, advanced microscopy, protein biochemistry, multi-omics (proteomics and ribosome profiling), and in vivo disease models — connecting mechanisms observed at the molecular level to outcomes in living systems. Broadly, I'm driven by translational questions: how does fundamental biology illuminate disease, and how can that understanding be turned into real therapeutic strategies?

My Services

No Consultancies Available Yet

No consulancies are available at the moment.